Colorectal oncogenesis;Oncogenèse colorectale

Bulletin du Cancer

Volumn 97, Issue 11, 2010, Pages 1311-1321

  Laurent Puig, P ^a   Agostini, J ^a   Maley, K ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

CIMP phenotype; CIN phenotype; Colorectal cancer; MSI phenotype

Indexed keywords

APC PROTEIN; B RAF KINASE; BETA CATENIN; CASPASE 5; PROTEIN BAX; PROTEIN P53; SMAD2 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

APOPTOSIS; CELL CYCLE; CHROMOSOME 17; CHROMOSOME 18; CHROMOSOME 22; CHROMOSOME 5; CHROMOSOME 8; COLON CARCINOGENESIS; COLORECTAL CANCER; GENE INACTIVATION; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC STABILITY; HUMAN; MALIGNANT TRANSFORMATION; REVIEW;

EID: 78650102987     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2010.1216     Document Type: Review

References (62)

1. Fodde R, Smits R, Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 2001 ; 1 : 55-67. (Pubitemid 33741881)
2. Fodde R, Kuipers J, Rosenberg C, Smits R, Kielman M, Gaspar C, et al. Mutations in the APC tumor suppressor gene cause chromosomal instability. Nat Cell Biol 2001 ; 3 : 433-8. (Pubitemid 32288454)
3. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, et al. Mutations of mitotic checkpoint genes in human cancers. Nature 1998 ; 392 : 300-3. (Pubitemid 28155105)
4. Gualberto A, Aldape K, Kozakiewicz K, Tlsty TD. An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control. Proc Natl Acad Sci USA 1998 ; 95 : 5166-71. (Pubitemid 28208569)
5. Killian A, Di Fiore F, Le Pessot F, Blanchard F, Lamy A, Raux G, et al. A simple method for the routine detection of somatic quantitative genetic alterations in colorectal cancer. Gastroenterology 2007 ; 132 : 645-53.
6. Nishida N, Nagasaka T, Kashiwagi K, Boland CR, Goel A. High copy amplification of the Aurora-A gene is associated with chromosomal instability phenotype in human colorectal cancers. Cancer Biol Ther 2007 ; 6 : 525-33. (Pubitemid 47328326)
7. Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, Souza B, et al. A homologue of Drosophila Aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J 1998 ; 17 : 3052-65. (Pubitemid 28254378)
8. Barber TD, McManus K, Yuen KW, Reis M, Parmigiani G, Shen D, et al. Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers. Proc Natl Acad Sci USA 2008 ; 105 : 3443-8. (Pubitemid 351723572)
9. Olschwang S, Hamelin R, Laurent-Puig P, Thuille B, De Rycke Y, Li YJ, et al. Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci USA 1997 ; 94 : 12122-7. (Pubitemid 27467853)
10. Duval A, Hamelin R. Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability. Cancer Res 2002 ; 62 : 2447-54. (Pubitemid 34462716)
11. Kondo Y, Issa JP. Epigenetic changes in colorectal cancer. Cancer Metastasis Rev 2004 ; 23 : 29-39.
12. Rashid A, Issa JP. CpG island methylation in gastroenterologic neoplasia: a maturing field. Gastroenterology 2004 ; 127 : 1578-88. (Pubitemid 39457781)
13. Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer 2004 ; 4 : 988-93.
14. Barault L, Charon-Barra C, Jooste V, de la Vega MF, Martin L, Roignot P, et al. Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. Cancer Res 2008 ; 68 : 8541-6.
15. El-Deiry WS, Nelkin BD, Celano P, Yen RW, Falco JP, Hamilton SR, et al. High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc Natl Acad Sci USA 1991 ; 88 : 3470-4. (Pubitemid 21916643)
16. Wu J, Issa JP, Herman J, Bassett Jr. DE, Nelkin BD, Baylin SB. Expression of an exogenous eukaryotic DNA methyltransferase gene induces transformation of NIH3T3 cells. Proc Natl Acad Sci USA 1993 ; 90 : 8891-5. (Pubitemid 23306416)
17. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006 ; 38 : 787-93. (Pubitemid 43980599)
18. Ogino S, Kawasaki T, Kirkner GJ, Kraft P, Loda M, Fuchs CS. Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. J Mol Diagn 2007 ; 9 : 305-14. (Pubitemid 47305066)
19. Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992 ; 359 : 235-7.
20. Laurent-Puig P, Beroud C, Soussi T. APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res 1998 ; 26 : 269-70. (Pubitemid 28291541)
21. Goss KH, Groden J. Biology of the adenomatous polyposis coli tumor suppressor. J Clin Oncol 2000 ; 18 : 1967-79. (Pubitemid 30261936)
22. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW. Mutational analysis of the APC/beta-catenin/TCF pathway in colorectal cancer. Cancer Res 1998 ; 58 : 1130-4. (Pubitemid 28183198)
23. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Identification of c-MYC as a target of the APC pathway. Science 1998 ; 281 : 1509-12. (Pubitemid 28425575)
24. Duval A, Gayet J, Zhou XP, Iacopetta B, Thomas G, Hamelin R. Frequent frameshift mutations of the TCF4 gene in colorectal cancers with microsatellite instability. Cancer Res 1999 ; 59 : 4213-5. (Pubitemid 29418728)
25. Heldin CH, Miyazono K, ten Dijke P. TGFβ signalling from cell membrane to nucleus through SMAD proteins. Nature 1997 ; 390 : 465-71.
26. Slingerland JM, Hengst L, Pan CH, Alexander D, Stampfer MR, Reed SI. A novel inhibitor of cyclin-CDK activity detected in transforming growth factor beta-arrested epithelial cells. Mol Cell Biol 1994 ; 14 : 3683-94. (Pubitemid 24160776)
27. Thiagalingam S, Lengauer C, Leach FS, Schutte M, Hahn SA, Overhauser J, et al. Evaluation of candidate tumor suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 1996 ; 13 : 343-6. (Pubitemid 26230501)
28. Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, et al. MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 1996 ; 86 : 543-52. (Pubitemid 26299486)
29. Parsons R, Myeroff LL, Liu B, Willson JK, Markowitz SD, Kinzler KW, et al. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 1995 ; 55 : 5548-50.
30. Souza RF, Appel R, Yin J, Wang S, Smolinski KN, Abraham JM, et al. Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumors. Nat Genet 1996 ; 14 : 255-7.
31. Lane DP. Cancer. p53, guardian of the genome. Nature 1992 ; 358 : 15-6.
32. Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC, et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997 ; 275 : 967-9. (Pubitemid 27087710)
33. Yarden Y. The EGFR family and its ligands in human cancer. Signalling mechanisms and therapeutic opportunities. Eur J Cancer 2001 ; 37 (Suppl 4) : S3-8.
34. Radinsky R, Risin S, Fan D, Dong Z, Bielenberg D, Bucana CD, et al. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res 1995 ; 1 : 19-31.
35. Cohen SJ, Cohen RB, Meropol NJ. Targeting signal transduction pathways in colorectal cancer: more than skin deep. J Clin Oncol 2005 ; 23 : 5374-85. (Pubitemid 46206991)
36. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001 ; 2 : 127-37.
37. Tong WM, Ellinger A, Sheinin Y, Cross HS. Epidermal growth factor receptor expression in primary cultured human colorectal carcinoma cells. Br J Cancer 1998 ; 77 : 1792-8. (Pubitemid 28254613)
38. Roberts RB, Min L, Washington MK, Olsen SJ, Settle SH, Coffey RJ, et al. Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis. Proc Natl Acad Sci USA 2002 ; 99 : 1521-6. (Pubitemid 34136525)
39. Laurent-Puig P, Cayre A, Manceau G, Buc E, Bachet JB, Lecomte T, et al. Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer. J Clin Oncol 2009 ; 27 : 5924-30.
40. Bos JL. RAS oncogenes in human cancer: a review. Cancer Res 1989 ; 49 : 4682-9. (Pubitemid 19213607)
41. Bamford S, Dawson E, Forbes S, Clements J, Pettett R, Dogan A, et al. The COSMIC (catalogue of somatic mutations in cancer) database and website. Br J Cancer 2004 ; 91 : 355-8. (Pubitemid 39037083)
42. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature 2002 ; 417 : 949-54. (Pubitemid 34716871)
43. Barault L, Veyrie N, Jooste V, Lecorre D, Chapusot C, Ferraz JM, et al. Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers. Int J Cancer 2008 ; 122 : 2255-9.
44. Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature 2002 ; 418 : 934. (Pubitemid 34976022)
45. Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB, et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha. Curr Biol 1997 ; 7 : 261-9. (Pubitemid 27176852)
46. Vanhaesebroeck B, Alessi DR. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 2000 ; 346 (Pt 3) : 561-76. (Pubitemid 30171014)
47. von Manteuffel SR, Dennis PB, Pullen N, Gingras AC, Sonenberg N, Thomas G. The insulin-induced signalling pathway leading to S6 and initiation factor 4E binding protein 1 phosphorylation bifurcates at a rapamycin-sensitive point immediately upstream of p70s6k. Mol Cell Biol 1997 ; 17 : 5426-36. (Pubitemid 27357640)
48. Burnett PE, Barrow RK, Cohen NA, Snyder SH, Sabatini DM. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc Natl Acad Sci USA 1998 ; 95 : 1432-7. (Pubitemid 28103409)
49. Nave BT, Ouwens M, Withers DJ, Alessi DR, Shepherd PR. Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem J 1999 ; 344 (Pt 2) : 427-31. (Pubitemid 30011599)
50. Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 1998 ; 12 : 3499-511. (Pubitemid 28553242)
51. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998 ; 282 : 1318-21. (Pubitemid 28524494)
52. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, et al. AKT phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997 ; 91 : 231-41. (Pubitemid 27456390)
53. Ikenoue T, Kanai F, Hikiba Y, Obata T, Tanaka Y, Imamura J, et al. Functional analysis of PIK3CA gene mutations in human colorectal cancer. Cancer Res 2005 ; 65 : 4562-7. (Pubitemid 40740791)
54. Samuels Y, Wang Z, Bardelli A, Silliman N, Ptak J, Szabo S, et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 2004 ; 304 : 554. (Pubitemid 38541907)
55. Kang S, Bader AG, Vogt PK. Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. Proc Natl Acad Sci USA 2005 ; 102 : 802-7. (Pubitemid 40282746)
56. Bader AG, Kang S, Vogt PK. Cancer-specific mutations in PIK3CA are oncogenic in vivo. Proc Natl Acad Sci USA 2006 ; 103 : 1475-9. (Pubitemid 43191190)
57. Frayling IM, Bodmer WF, Tomlinson IP. Allele loss in colorectal cancer at the Cowden disease/juvenile polyposis locus on 10q. Cancer Genet Cytogenet 1997 ; 97 : 64-9. (Pubitemid 27318479)
58. Goel A, Arnold CN, Niedzwiecki D, Carethers JM, Dowell JM, Wasserman L, et al. Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers. Cancer Res 2004 ; 64 : 3014-21. (Pubitemid 38581399)
59. Guanti G, Resta N, Simone C, Cariola F, Demma I, Fiorente P, et al. Involvement of PTEN mutations in the genetic pathways of colorectal cancerogenesis. Hum Mol Genet 2000 ; 9 : 283-7. (Pubitemid 30052752)
60. Shin KH, Park YJ, Park JG. PTEN gene mutations in colorectal cancers displaying microsatellite instability. Cancer Lett 2001 ; 174 : 189-94. (Pubitemid 33022679)
61. Wang ZJ, Taylor F, Churchman M, Norbury G, Tomlinson I. Genetic pathways of colorectal carcinogenesis rarely involve the PTEN and LKB1 genes outside the inherited hamartoma syndromes. Am J Pathol 1998 ; 153 : 363-6. (Pubitemid 28373647)
62. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, et al. The genomic landscapes of human breast and colorectal cancers. Science 2007 ; 318 : 1108-13. (Pubitemid 350134889)